Compound information
- Natural Products
- ZC552628
- Molecular Formula
- C18H27N3O4S
- Molecular Weight
- 381.172227344 g/mol
- Structure
-
- IUPAC Name
- benzyl (3S)-3-[(1-methyl-4-piperidyl)sulfamoyl]pyrrolidine-1-carboxylate
- InChI
- InChI=1S/C18H27N3O4S/c1-20-10-7-16(8-11-20)19-26(23,24)17-9-12-21(13-17)18(22)25-14-15-5-3-2-4-6-15/h2-6,16-17,19H,7-14H2,1H3/t17-/m0/s1
- InChI Key
- CUVPYANXQACRMQ-KRWDZBQOSA-N
- SMILES
- CN1CCC(NS(=O)(=O)[C@H]2CCN(C(=O)OCc3ccccc3)C2)CC1
- Source
- ZINC000253427014
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 78.95 Å2 | LogP | 1.582 |
LogS | -1.587 | LogD | 1.469 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.029 | Pgp substrate | 0.942 |
HIA | 0.964 | F20 % | 0.981 |
F30 % | 0.552 | Caco-2 | -5.341 |
MDCK | -5.125 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.03 | PPB | 40.793 |
VD | 1.591 | Fu | -0.056 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.687 |
CYP2A6 substrate | 0.358 | CYP2B6 substrate | 0.653 |
CYP2C19 inhibitor | 0.078 | CYP2C19 substrate | 0.858 |
CYP2C8 substrate | 0.703 | CYP2C9 inhibitor | 0.018 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.091 |
CYP2D6 substrate | 0.968 | CYP2E1 substrate | 0.18 |
CYP3A4 inhibitor | 0.024 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.553 | CL | 4.648 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.007 | Hepatotoxicity | 0.844 |
Mutagenicity | 0.963 | Rat Oral Acute Toxicity | 0.634 |
FDAMDD | 0.704 | Skin Sensitization | 0.661 |
Carcinogenicity | 0.058 | Eye Corrosion | 0.003 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.93 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.391 | IGC50 | 2.225 |
LC50FM | -1.464 | LC50DM | -4.919 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.689 | NR-AR-LBD | 0.226 |
NR-AhR | 0.006 | NR-Aromatase | 0.021 |
NR-ER | 0.331 | NR-ER-LBD | 0.305 |
NR-PPAR-gamma | 0.096 | SR-ARE | 0.034 |
SR-ATAD5 | 0.269 | SR-HSE | 0.127 |
SR-MMP | 0.01 | SR-p53 | 0.039 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.